Skip to main content
Clinical Trials/NL-OMON49449
NL-OMON49449
Completed
Not Applicable

The impact of norepinephrine on the dynamic aspect of brain activity - Dyn-Neuromod

niversiteit Leiden0 sites36 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
scientific investigation of healthy subjects
Sponsor
niversiteit Leiden
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
August 29, 2022
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversiteit Leiden

Eligibility Criteria

Inclusion Criteria

  • Healthy adult subjects with no history of neurological disorder/disease and no
  • counter\-indications to 3 Tesla MRI or to atomoxetine, and no personal
  • relationship with the researchers will be included in this study. All
  • participants will be right\-handed with normal vision or contact lenses.

Exclusion Criteria

  • Significant history of head trauma, premature birth, learning disabilities,
  • neurological or psychiatric illness. Heart arrhythmia, glaucoma, congenital eye
  • diseases, hyperopia, myopia, hypertension and use of anti\-depressants or
  • psychotropic medication and possible pregnancy (in adult females). MRI
  • contra\-indications, including metal implants and claustrophobia. Smoking more
  • than five cigarettes a day \- to avoid nicotine withdrawal effects during the
  • study. Alcohol consumption \< 24 hours before study, caffeine consumption \< 3
  • hours before study.
  • These criteria will be assessed by a self\-report questionnaire administered
  • during pre\-screening.

Outcomes

Primary Outcomes

Not specified

Similar Trials